Vaxart Inc (VXRT)

6.94 -0.26  -3.61% NASDAQ Oct 15, 16:00 6.96 +0.02  +0.29% After-Hours: 20:00 USD
View Full Chart
Price Chart
View All VXRT News

News

View All Events

Events

Date Type Description
11/12/2021 Earnings Results Q3 2021 Earnings Results
08/05/2021 Earnings Results Q2 2021 Earnings Results
06/16/2021 09:30 EST AGM 2021 Annual General Meeting
05/06/2021 Earnings Results Q1 2021 Earnings Results
02/25/2021 Earnings Results Q4 2020 Earnings Results
11/12/2020 Earnings Results Q3 2020 Earnings Results
View All Performance Charts

Total Returns Comparison

Ratings & Reports

Advertisement
Edit

Profile

  • Description: Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
  • URL: https://www.vaxart.com
  • Investor Relations URL: https://investors.vaxart.com/
  • HQ State/Province: California
  • Sector: Healthcare
  • Industry: Biotechnology
  • Equity Style: Small Cap/Blend
  • Next Earnings Release: Nov. 12, 2021
  • Last Earnings Release: Aug. 05, 2021
  • Next Ex-Dividend Date: N/A
  • Last Ex-Dividend Date: Nov. 09, 2012

Top Fund Holders

Symbol Name Weighting
FNDRX FRC Founders Index 0.32%

Comparables

Edit
Advertisement

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}

Please note that this feature is only available as an add-on to YCharts subscriptions.


Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{root.upsell.info.call_to_action}} No credit card required.

Already a subscriber? Sign in.